Linked Life Data

16483945

Source:http://linkedlifedata.com/resource/pubmed/id/16483945

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2006-2-17
pubmed:abstractText
Surgery is the only curative treatment for patients with colorectal liver metastases with recent reports documenting 5-year survival results of 40-50%. In unresectable patients, the use of more effective regimens of chemotherapy has contributed to improve the results of survival at short term and new onco-surgical strategies have emerged. By allowing resection of previously unresectable liver metastases, these onco-surgical strategies now offer 15-20% of patients a real potential of long-term remission (5-year survival 30-40%). Chemotherapy is also used in the adjuvant setting, to prevent post-operative recurrence. In resectable metastases, it may also be used as neo-adjuvant treatment to control tumor progression before surgery and to select the patients likely to really benefit from liver resection. The objective of this article is to describe this multidisciplinary approach of liver metastases and to report the results of these new strategies.
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1769-6917
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
93 Suppl 1
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S45-9
pubmed:dateRevised
2009-11-11
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
[Induction chemotherapy and surgery of colorectal liver metastases].
pubmed:affiliation
Centre hépatobiliaire, Hôpital Paul Brousse, Université de Paris-Sud, 12, avenue Paul-Vaillant-Couturier, 94804 Villejuif Cedex. rene.adam@pbr.ap-hop-paris.fr
pubmed:publicationType
Journal Article, English Abstract, Review